Applying 14C-AMS in neonatal research and care

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 53, Issue 5-6, 2010, Pages 352-354

  Vuong, L ^a   Lohstroh, P ^a   Blood, A ^b   Vasquez, H ^b   Vogel, J ^a  

^a Vitalea Science   (United States)

^b LOMA LINDA UNIVERSITY CHILDREN S HOSPITAL   (United States)

Author keywords

14C; AMS; Cholestasis; Neonatal; Ursodiol

Indexed keywords

CLINICAL RESEARCH; DROPS; DRUG PRODUCTS;

14C; ACCELERATOR MASS SPECTROMETRY; CHOLESTASI; CLINICAL TOOLS; DIRECT MEASUREMENT; MEASUREMENTS OF; NEONATAL; RESEARCH TOOLS; SINGLE DROPS; URSODIOL;

MASS SPECTROMETRY;

CARBON 14; URSODEOXYCHOLIC ACID;

ACCELERATOR MASS SPECTROMETRY; BODY FLUID; CHOLESTASIS; CLINICAL ARTICLE; CONFERENCE PAPER; DRUG ABSORPTION; DRUG BIOAVAILABILITY; HUMAN; ISOTOPE LABELING; MASS SPECTROMETRY; MAXIMUM PLASMA CONCENTRATION; NEWBORN CARE; RADIOACTIVITY;

EID: 77955146642     PISSN: 03624803     EISSN: 10991344     Source Type: Journal    
DOI: 10.1002/jlcr.1769     Document Type: Conference Paper

References (10)

1. R. M. Ward, W. E. Benitz, D. K. Benjamin Jr, L. Blackmon, G. P. Giacoia, M. Hudak, T. Lasky, W. Rodriguez, A. Selen, Clin. Ther. 2006 28,1385-1398.
2. I. H. Bartelink, C. M. Rademaker, A. F. Schobben, J. N. van den Anker, Clin. Pharmacokinet. 2006 45, 1077-1097.
3. B. J. Anderson, N. H. Holford. Annu. Rev. Pharmacol. Toxicol. 2008 48, 303-332.
4. K. Allegaert, J. N. van den Anker, G. Naulaers, J. de Hoon, Curr. Clin. Pharmacol. 2007 2, 23-29.
5. E. Chatelut, Fund. Clin. Pharmacol. 2008 22, 575-578.
6. H. Campbell, S. A. M. Surry, E. M. Royle, Arch. Dis. Child. 1998 79, 192-197.
7. E. Burgess, N. Singhal, H. Amin, D. D. McMillan, H. Devrome, Arch. Dis. Child. 2003 88, F280-F285.
8. H. O. Ballard, L. A. Shook, N. S. Desai, K. J. Anand, J. Perinatol. 2004 24, 409-415.
9. www.PubMed.gov U.S. National Library of Medicine.
10. J. Vogel, A. Love, Meth. Enzym. 2005 402, 402-422.